Trial intelligence / Profile preview

Prednisone in acute heart failure

NCT05916586Completed

Start
Aug 2023
Primary completion
Apr 2024
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, open-label trial of prednisone in Acute Heart Failure (AHF) (2 arms). Primary endpoint: Change of C-reactive Protein level at 7 days. Started Aug 2023; status: completed.

02

Drugs

prednisone
03

Conditions

Acute Heart Failure (AHF)

Beyond the preview

Go deeper on NCT05916586.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05916586.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call